Gambaran Reseptor Hormonal Karsinoma Payudara Duktus Invasif Tipe Non Spesial (No Special Type Not Otherwise Specified) pada Wanita Usia 40 Tahun Kebawah Periode 2014-2016 di RSUP HAM Medan
DAFTAR PUSTAKA
1. Cancer. [internet] 2016. [cited 2016 April 14] Available from:
http://www.who.int/cancer/en/
2. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and
Prevalence Worldwide in 2012. [internet] 2016. [cited 2016 April 14]
Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
3. Genes and human disease. [internet] 2016. [cited 2016 April 14] Available
from: http://www.who.int/genomics/public/geneticdiseases/en/index3.html
4. Breast Cancer Statistics. [internet] 2016. [cited 2016 April 14] Available
from: http://www.cdc.gov/cancer/breast/statistics/
5. HILANGKAN MITOS TENTANG KANKER. [internet] 8 Mei 2014.
[cited
2016
April
14]
Available
from:
http://www.depkes.go,id/article/print/2014070001/hilangkan-mitostentang-kanker.html
6. Colditz G, Chia KS. WHO Classification of Tumours of The Breast.
4th.ed. Lyon: International Agency for Research on Cancer; 2012. 14-7
7. Breast Cancer-American Cancer Society. [internet] 2016. [cited 2016
April 22] Available from: www.cancer.org>acs>cid>003090-pdf
8. Assi HA, Khoury KE, Dbouk H, et al. (2013) “Epidemiology and
prognosis of breast cancer in young women”. Journal of Thoracic Disease.
5,(1),2-3
9. Allred C, Miller K, Viale G, Brogi E, Isola J. WHO Classification of
Tumours of The Breast. 4th.ed. Lyon: International Agency for Research
on Cancer; 2012. 22-3
10. Eroschenko VP. diFiore’s Atlas of Histology: with Functional
Correlations. 11th.ed. United States of America: Lippincott Williams &
Wilkins; 2008. 482-6
11. Mescher AL. JUNQUEIRA’S Basic Histology: TEXT & ATLAS.12th.ed.
United States of America: The McGraw-Hill Companies, Inc; 2010.
12. Martini FH, Nath JL, Bartholomew EF. Fundamentals of Anatomy &
Physiology. 9th.ed. United States of America: Pearson Education, Inc;
2012. 1062-4
13. Devita VT, Hellman TSL, Rosenberg SA. Devita, Hellman and
Rosenberg’s CANCER : Principles & Practice of Oncology. United States
of America: Lippincott Williams & Wilkins ; 2008
14. Bhat S. SRB’s Manual of Surgery. 4th.ed. New Delhi: Jaypee Brothers
Medical Publisher (P) LTD; 2013. 563-5
15. Woodson AH, Profato JL, Muse KI, Litton JK. (2013) “Breast cancer in
the young: role of the geneticist”. Journal of Thoracic Disease.5,(1), 19-26
16. Bharat A, Aft RL, Gao F, et al. Patient and tumor characteristics
associated with increased mortality in young women (< or =40 years) with
breast cancer. J Surg Oncol 2009;100:248-51.
43
Universitas Sumatera Utara
44
17. Hartman M, Czene K, Reilly M, et al. Genetic implications of bilateral
breast cancer: a population based cohort study. Lancet Oncol 2005;6:37782.
18. Kollias J, Ellis IO, Elston CW, et al. Clinical and histological predictors of
contralateral breast cancer. Eur J Surg Oncol 1999;25:584-9.
19. Dabbs DJ. Breast PATHOLOGY. 1st.ed. China : Elsevier Inc; 2012. 42930
20. Ellis IO, Collins L, Ichihara S, MacGrogan G. WHO Classification of
Tumours of The Breast. 4th.ed. Lyon: International Agency for Research
on Cancer; 2012. 34-8
21. Benson JR, Gui G, Tuttle TM. EARLY Breast Cancer: From Screening to
Multidisciplinary Management. Boca Raton. Taylor & Francis Group;
2013. 269
22. Breast Cancer: What are the risk factors for breasts cancer. [internet] 4
April
2016
[cited
2016
May
13]
Available
from:
http://www.cdc.gov/cancer/breast/basic_info/risk_factors.htm
23. Wilson R, Britton P. WHO Classification of Tumours of The Breast.
4th.ed. Lyon: International Agency for Research on Cancer; 2012. 17-8
24. Christinat A, Lascio SD, Pagani O. Hormonal therapies in young breast
cancer patients: when, what and for how long?. Journal of Thoracic
Disease. 2013; 5(1): 36-46
25. Treatments for Hormone-Receptor-Positive Breast Cancer. [internet] 22
Januari
2014.
[cited
2016
May
22]
Available
from:
http://www.breastcancer.org/symptoms/diagnosis/hormonestatus/treatment_hrpos
26. Salem DS, Kamal RM, Mansour SM, Salah LA, Wessam R. Breast
imaging in the young: the role of magnetic resonance imaging in breast
cancer screening, diagnosis and follow-up. Journal of Thoracic Disease.
2013; 5(1): 9-18
27. HER2 Status. [internet] 16 Mei 2016. [cited 2016 May 22] Available
from: http://www.breastcancer.org/symptoms/diagnosis/her2
28. Jon Godwin, Samantha Hinsley, Ariel Zwenger. Adjuvant bisphosphonate
treatment in early breast cancer: meta-analyses of individual patient data
from randomised trials. January 2015, pp. 2-6.
29. Hormone Receptor Status. [internet] 27 Januari 2016. [cited 2016 May 22]
Available
from:
http://www.breastcancer.org/symptoms/diagnosis/hormone_status
30. Understanding Hormone Receptors and What They Do. [internet] 22
Januari
2014.
[cited
2016
May
22]
Available
from:
http://www.breastcancer.org/symptoms/diagnosis/hormonestatus/understanding
31. Collins LC, Marotti JD, Gelber S, et al. Pathologic features and molecular
phenotype by patient age in a large cohort of young women with breast
cancer. Breast Cancer Res Treat 2012; 131:1061-6
Universitas Sumatera Utara
45
32. Chan M, Chang MC, Gonzalez R, Lategan B, del Barco E, Vera-Badillo F,
et al. Outcomes of Estrogen Receptor Negative and Progesterone Receptor
Positive Breast Cancer. PLoS ONE. 2015 July; 10(7): e0132449
33. Gross JM, Yee D. How does the estrogen receptor work?. Breast Cancer
Res. 2002; 4: 62-4
34. Zhenlin Bai and Ronald Gust. Breast cancer, Estrogen Receptor and
Ligands. Arch Pharm Chem Life Sci. 2009; 342: 133-49
35. Welboren W, Stunnenberg HG, Sweep FCGJ, Span PN. Identifying
estrogen receptor target genes. Elsevier. 2007 September; 1(2): 138-43
36. Lange CA, Yee D. Progesterone and Breast Cancer. Womens Health
(Lond Engl). 2008 March; 4(2): 151-62
37. Gao X, Nawaz Z. Role of steroid receptor coactivators and corepressor of
progesterone receptors in breast cancer. Breast Cancer Research. 2002;
4(5): 182-6
38. Li Y, Rosen JM. Stem/progenitor cells in mouse mammary gland
development and breast cancer. J Mammary Gland Biol Neoplasia. 2005;
10(1):17-24.
39. Moasser MM. The Oncogen HER2; Its signaling and transforming
functions and its role in human cancer pathogenesis. Oncogene. 2007
October; 26(45): 6469-87
40. Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS. ErbB2, but not
ErbB1, reinitiates proliferation and induces luminal repopulation in
epithelial acini. Nat Cell Biol. 2001; 3:785-92
41. Iqbal N, Iqbal N. Human Epidermal Growth Factor Receptor 2 (HER2) in
Cancers: Overexpression and Therapeutic Implications. Hindawi
Publishing Corporation. 2014: 1-9
42. Kartika I, Maulani H, Sulastri H, Yuwono. EKSPRESI PROTEIN HER2/neu, STATUS RESEPTOR ESTROGEN DAN PROGESTERON PADA
BERBAGAI DERAJAT KEGANASAN KARSINOMA PAYUDARA
DUKTAL INVASIF WANITA USIA MUDA. Majalah Patologi. 2009
Januari; 18(1): 32-40
43. Thapa B, Singh Y, Sayami P, Shrestha U, Sapkota R, Sayami G. Breast
Cancer in Young Women from a Low Risk Population in Nepal. Asian
Pacific Journal of Cancer Prevention. 2013; 14(9): 5095-99
44. Gabriel C, Domchek S. Breast cancer in young women. BioMed Central.
2010; 12: 212
45. Lund M, Butler E, Hair B, Ward K, Andrews J, et al. Cancer. 2010: 254958
46. Devi C, Tang T, Corbex M. Incidence and risk factors for breast cancer
subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay
and natives of Sarawak, Malaysia. International Journal of Cancer. 2012;
131: 2869-77
47. Cvetanovic A, Popovic L, Filipovic S, Trifunovic J, Zivkovic N, et al.
Young age and pathological features predict breast cancer outcome –
report from a dual Institution experience in Serbia. JBUON. 2015; 20(6):
1407-13
Universitas Sumatera Utara
46
48. Recăreanu F, Simionescu C, Georgescu C, Pirici E. Ductal invasive
mammary carcinoma – Clinicopathological prognostic factors related to
immunohistochemical expression of hormonal receptors and Her2/neu
oncoprotein. Romanian Journal of Morphology and Embryology. 2012; 52
(3 Suppl): 1059-64
49. Almasri N, Hamad M. Immunohistochemical evaluation of human
epidermal growth factor receptor 2 and estrogen and progesterone
receptors in breast carcinoma in Jordan. Breast Cancer Research. 2005
May; 7(7): 598-604
Universitas Sumatera Utara
1. Cancer. [internet] 2016. [cited 2016 April 14] Available from:
http://www.who.int/cancer/en/
2. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and
Prevalence Worldwide in 2012. [internet] 2016. [cited 2016 April 14]
Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
3. Genes and human disease. [internet] 2016. [cited 2016 April 14] Available
from: http://www.who.int/genomics/public/geneticdiseases/en/index3.html
4. Breast Cancer Statistics. [internet] 2016. [cited 2016 April 14] Available
from: http://www.cdc.gov/cancer/breast/statistics/
5. HILANGKAN MITOS TENTANG KANKER. [internet] 8 Mei 2014.
[cited
2016
April
14]
Available
from:
http://www.depkes.go,id/article/print/2014070001/hilangkan-mitostentang-kanker.html
6. Colditz G, Chia KS. WHO Classification of Tumours of The Breast.
4th.ed. Lyon: International Agency for Research on Cancer; 2012. 14-7
7. Breast Cancer-American Cancer Society. [internet] 2016. [cited 2016
April 22] Available from: www.cancer.org>acs>cid>003090-pdf
8. Assi HA, Khoury KE, Dbouk H, et al. (2013) “Epidemiology and
prognosis of breast cancer in young women”. Journal of Thoracic Disease.
5,(1),2-3
9. Allred C, Miller K, Viale G, Brogi E, Isola J. WHO Classification of
Tumours of The Breast. 4th.ed. Lyon: International Agency for Research
on Cancer; 2012. 22-3
10. Eroschenko VP. diFiore’s Atlas of Histology: with Functional
Correlations. 11th.ed. United States of America: Lippincott Williams &
Wilkins; 2008. 482-6
11. Mescher AL. JUNQUEIRA’S Basic Histology: TEXT & ATLAS.12th.ed.
United States of America: The McGraw-Hill Companies, Inc; 2010.
12. Martini FH, Nath JL, Bartholomew EF. Fundamentals of Anatomy &
Physiology. 9th.ed. United States of America: Pearson Education, Inc;
2012. 1062-4
13. Devita VT, Hellman TSL, Rosenberg SA. Devita, Hellman and
Rosenberg’s CANCER : Principles & Practice of Oncology. United States
of America: Lippincott Williams & Wilkins ; 2008
14. Bhat S. SRB’s Manual of Surgery. 4th.ed. New Delhi: Jaypee Brothers
Medical Publisher (P) LTD; 2013. 563-5
15. Woodson AH, Profato JL, Muse KI, Litton JK. (2013) “Breast cancer in
the young: role of the geneticist”. Journal of Thoracic Disease.5,(1), 19-26
16. Bharat A, Aft RL, Gao F, et al. Patient and tumor characteristics
associated with increased mortality in young women (< or =40 years) with
breast cancer. J Surg Oncol 2009;100:248-51.
43
Universitas Sumatera Utara
44
17. Hartman M, Czene K, Reilly M, et al. Genetic implications of bilateral
breast cancer: a population based cohort study. Lancet Oncol 2005;6:37782.
18. Kollias J, Ellis IO, Elston CW, et al. Clinical and histological predictors of
contralateral breast cancer. Eur J Surg Oncol 1999;25:584-9.
19. Dabbs DJ. Breast PATHOLOGY. 1st.ed. China : Elsevier Inc; 2012. 42930
20. Ellis IO, Collins L, Ichihara S, MacGrogan G. WHO Classification of
Tumours of The Breast. 4th.ed. Lyon: International Agency for Research
on Cancer; 2012. 34-8
21. Benson JR, Gui G, Tuttle TM. EARLY Breast Cancer: From Screening to
Multidisciplinary Management. Boca Raton. Taylor & Francis Group;
2013. 269
22. Breast Cancer: What are the risk factors for breasts cancer. [internet] 4
April
2016
[cited
2016
May
13]
Available
from:
http://www.cdc.gov/cancer/breast/basic_info/risk_factors.htm
23. Wilson R, Britton P. WHO Classification of Tumours of The Breast.
4th.ed. Lyon: International Agency for Research on Cancer; 2012. 17-8
24. Christinat A, Lascio SD, Pagani O. Hormonal therapies in young breast
cancer patients: when, what and for how long?. Journal of Thoracic
Disease. 2013; 5(1): 36-46
25. Treatments for Hormone-Receptor-Positive Breast Cancer. [internet] 22
Januari
2014.
[cited
2016
May
22]
Available
from:
http://www.breastcancer.org/symptoms/diagnosis/hormonestatus/treatment_hrpos
26. Salem DS, Kamal RM, Mansour SM, Salah LA, Wessam R. Breast
imaging in the young: the role of magnetic resonance imaging in breast
cancer screening, diagnosis and follow-up. Journal of Thoracic Disease.
2013; 5(1): 9-18
27. HER2 Status. [internet] 16 Mei 2016. [cited 2016 May 22] Available
from: http://www.breastcancer.org/symptoms/diagnosis/her2
28. Jon Godwin, Samantha Hinsley, Ariel Zwenger. Adjuvant bisphosphonate
treatment in early breast cancer: meta-analyses of individual patient data
from randomised trials. January 2015, pp. 2-6.
29. Hormone Receptor Status. [internet] 27 Januari 2016. [cited 2016 May 22]
Available
from:
http://www.breastcancer.org/symptoms/diagnosis/hormone_status
30. Understanding Hormone Receptors and What They Do. [internet] 22
Januari
2014.
[cited
2016
May
22]
Available
from:
http://www.breastcancer.org/symptoms/diagnosis/hormonestatus/understanding
31. Collins LC, Marotti JD, Gelber S, et al. Pathologic features and molecular
phenotype by patient age in a large cohort of young women with breast
cancer. Breast Cancer Res Treat 2012; 131:1061-6
Universitas Sumatera Utara
45
32. Chan M, Chang MC, Gonzalez R, Lategan B, del Barco E, Vera-Badillo F,
et al. Outcomes of Estrogen Receptor Negative and Progesterone Receptor
Positive Breast Cancer. PLoS ONE. 2015 July; 10(7): e0132449
33. Gross JM, Yee D. How does the estrogen receptor work?. Breast Cancer
Res. 2002; 4: 62-4
34. Zhenlin Bai and Ronald Gust. Breast cancer, Estrogen Receptor and
Ligands. Arch Pharm Chem Life Sci. 2009; 342: 133-49
35. Welboren W, Stunnenberg HG, Sweep FCGJ, Span PN. Identifying
estrogen receptor target genes. Elsevier. 2007 September; 1(2): 138-43
36. Lange CA, Yee D. Progesterone and Breast Cancer. Womens Health
(Lond Engl). 2008 March; 4(2): 151-62
37. Gao X, Nawaz Z. Role of steroid receptor coactivators and corepressor of
progesterone receptors in breast cancer. Breast Cancer Research. 2002;
4(5): 182-6
38. Li Y, Rosen JM. Stem/progenitor cells in mouse mammary gland
development and breast cancer. J Mammary Gland Biol Neoplasia. 2005;
10(1):17-24.
39. Moasser MM. The Oncogen HER2; Its signaling and transforming
functions and its role in human cancer pathogenesis. Oncogene. 2007
October; 26(45): 6469-87
40. Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS. ErbB2, but not
ErbB1, reinitiates proliferation and induces luminal repopulation in
epithelial acini. Nat Cell Biol. 2001; 3:785-92
41. Iqbal N, Iqbal N. Human Epidermal Growth Factor Receptor 2 (HER2) in
Cancers: Overexpression and Therapeutic Implications. Hindawi
Publishing Corporation. 2014: 1-9
42. Kartika I, Maulani H, Sulastri H, Yuwono. EKSPRESI PROTEIN HER2/neu, STATUS RESEPTOR ESTROGEN DAN PROGESTERON PADA
BERBAGAI DERAJAT KEGANASAN KARSINOMA PAYUDARA
DUKTAL INVASIF WANITA USIA MUDA. Majalah Patologi. 2009
Januari; 18(1): 32-40
43. Thapa B, Singh Y, Sayami P, Shrestha U, Sapkota R, Sayami G. Breast
Cancer in Young Women from a Low Risk Population in Nepal. Asian
Pacific Journal of Cancer Prevention. 2013; 14(9): 5095-99
44. Gabriel C, Domchek S. Breast cancer in young women. BioMed Central.
2010; 12: 212
45. Lund M, Butler E, Hair B, Ward K, Andrews J, et al. Cancer. 2010: 254958
46. Devi C, Tang T, Corbex M. Incidence and risk factors for breast cancer
subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay
and natives of Sarawak, Malaysia. International Journal of Cancer. 2012;
131: 2869-77
47. Cvetanovic A, Popovic L, Filipovic S, Trifunovic J, Zivkovic N, et al.
Young age and pathological features predict breast cancer outcome –
report from a dual Institution experience in Serbia. JBUON. 2015; 20(6):
1407-13
Universitas Sumatera Utara
46
48. Recăreanu F, Simionescu C, Georgescu C, Pirici E. Ductal invasive
mammary carcinoma – Clinicopathological prognostic factors related to
immunohistochemical expression of hormonal receptors and Her2/neu
oncoprotein. Romanian Journal of Morphology and Embryology. 2012; 52
(3 Suppl): 1059-64
49. Almasri N, Hamad M. Immunohistochemical evaluation of human
epidermal growth factor receptor 2 and estrogen and progesterone
receptors in breast carcinoma in Jordan. Breast Cancer Research. 2005
May; 7(7): 598-604
Universitas Sumatera Utara